Psychosocial Profile of HIV Patients on HAART in Southern India

Jayakumar Palanisamy, Karthikeyan Murugesan, Senthilkumar Subramanian, Uma Devi, Pitchai Chinnapidaran, Rajamahendravarman Vellandi, Inigo Beula

.

DOI: 10.4236/wja.2011.14028                

Abstract

BACKGROUND: Mortality of HIV/AIDS patients comes down in India after the National Aids Control Organization started providing free Antiretroviral Therapy (ART) since 2004. Madurai ART Center started providing free ART since 2004. Psychosocial profile of this population explored in this study. METHODS: A cross sectional interview conducted during the year 2008 with semi structured questionnaire on HIV positive clients who are on Highly Active Anti-Retro- viral Therapy (HAART) for more than 6 months. Convenience sampling done and totally 433 clients were interviewed with informed consent. RESULTS: Three fourth (73.4%) of the clients know about ART centre through Government Hospitals or Primary Health Centre. Most of the Clients (98.6%) on ART are feels back to normal life or back to near normal life. Pill burden/ Pill fatigue perceived by clients is 4.8%.Discrimination perceived was 8.8% and mostly in their own house or by neighbors, but most of their children (99.2%) were not discriminated as per the clients. Spouse positive rate for the married clients was 61.5% and unmarried in this population was 4.6%. Major or minor psychological problems in this group were 39.7% and attempted suicide was 8.8%. Drug abuse (alcohol and smoking) while started on ART was 40.4% and the current abusers are 7.6%. CONCLUSION: This study supports effectiveness of free ART program and effective case referral from government institutions. High percentage of major or minor psychological problem warrants further exploratory study and may need psychological interventions in this population.

Keywords

HIV, AIDS, Antiretroviral Therapy, Psychosocial

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	National AIDS Control Organization, “Anti-Retroviral Treatment: A New Initiative,” 2010. http://www.nacoonline.org/Quick_Links/Directory/directory_ARV/
[2]	National AIDS Control Organization, “Prevention Strategies,” 2010. http://www.nacoonline.org/National_AIDS_Control_Program/Prevention_Strategies/
[3]	R. N. Alves, M. J. Kovacs, R. Stall and V. Paiva, “Psychosocial Aspects of HIV Infection among Women in Brazil,” Revista de Saúde Pública, Vol. 36, No. 4, 2002, pp. 32-39. doi:10.1590/S0034-89102002000500006
[4]	S. Floyd, A. C. Crampin, J. R. Glynn, M. Mwenebabu, S. Mnkhondia, B. Ngwira, B. Zaba and P. E. Fine, “The Long-Term Social and Economic Impact of HIV on the Spouses of Infected Individuals in Northern Malawi,” Tropical Medicine & International Health, Vol. 13, No. 4, 2008, pp. 520-531. doi:10.1111/j.1365-3156.2008.02030.x
[5]	National AIDS Control Organization, “FAQs on Sexual and Reproductive Health,” 2010. http://www.nacoonline.org/Quick_Links/FAQs/
[6]	V. Cambiano, F. C. Lampe, et al., “Long-Term Trends in Adherence to Antiretroviral Therapy from Start of HAART,” AIDS, Vol. 24, No. 8, 2010, pp. 1153-1162.
[7]	K. Van Vaerenbergh, “Study of the Impact of HIV Genotypic Drug Resistance Testing on Therapy Efficacy,” Verhandelingen-Koninklijke Academie voor Geneeskunde van Belgi?, Vol. 63, No. 5, 2001, pp. 447-473.
[8]	A. Palepu, M. W. Tyndall, K. Chan, E. Wood, J. S. Montaner and R. S. Hogg, “Initiating Highly Active Antiretroviral Therapy and Continuity of HIV Care: The Impact of Incarceration and Prison Release on Adherence and HIV Treatment Outcomes,” Antiviral Therapy, Vol. 9, No. 5, 2004, pp. 71371-71379.
[9]	F. Gutierrez, S. Padilla, M. Masiá, et al., “Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort,” PLoS One, Vol. 20, No. 1, 2006, p. e89. doi:10.1371/journal.pone.0000089
[10]	C. D. Evans, D. T. Eurich, D. A. Lamb, et al., “Retrospective Observational Assessment of Statin Adherence among Subjects Patronizing Different Types of Community Pharmacies in Canada,” Journal of Managed Care Pharmacy, Vol. 15, No. 6, 2009, pp. 4764-4784.
[11]	J. B. Nachega, M. Hislop, D. W. Dowdy, et al., “Adherence to Nonnucleoside Reverse Transcriptase Inhibitor- Based HIV Therapy and Virologic Outcomes,” Annals of Internal Medicine, Vol. 146, No. 8, 2007, pp. 564-735
[12]	A. M. Geretti, C. Smith, A. Haberl, et al., “Determinants of Virological Failure after Successful Viral Load Suppression in First-Line Highly Active Antiretroviral Therapy,” Antiviral Therapy, Vol. 13, No. 7, 2008, pp. 927- 936.
[13]	S. C. Kalichman, M. DiMarco, J. Austin, W. Luke and K. DiFonzo, “Stress, Social Support, and HIV-Status Disclosure to Family and Friends among HIV-Positive Men and Women,” Journal of Behavioral Medicine, Vol. 26, No. 4, 2003, pp. 315-332. doi:10.1023/A:1024252926930
[14]	L. Persson, B. Gullberg, B. S. Hanson, T. Moestrup and P. O. Ostergren, “HIV Infection: Social Network, Social Support, and CD4 Lymphocyte Values in Infected Homosexual Men in Malm?, Sweden,” Journal of Epidemiology & Community Health, Vol. 48, No. 6, 1994, pp. 580-585. doi:10.1136/jech.48.6.580
[15]	L. V. Edwards, “Perceived Social Support and HIV/ AIDS Medication Adherence among African American Women,” Qualitative Health Research, Vol. 16, No. 5, 2006, pp. 679-691. doi:10.1177/1049732305281597
[16]	J. Leserman, D. O. Perkins and D. L. Evans, “Coping with the Threat of AIDS: The Role of Social Support,” American Journal of Psychiatry, Vol. 149, 1992, pp. 1514-1520.
[17]	D. O. Perkins, E. J. Davidson, J. Leserman, D. Liao and D. L. Evans, “Personality Disorder in Patients Infected with HIV: A Controlled Study with Implications for Clinical Care,” American Journal of Psychiatry, Vol. 150, No. 2, 1993, pp. 309-315.
[18]	T. M. Wolf, P. M. Balson, et al., “Relationship of Coping Style to Affective State and Perceived Social Support in Asymptomatic and Symptomatic HIV-Infected Persons: Implications for Clinical Management,” Journal of Clinical Psychiatry, Vol. 52, No. 4, 1991, pp. 171-173.
[19]	K. I. Pakenham and M. Rinaldis, “The Role of Illness, Resources, Appraisal, and Coping Strategies in Adjustment to HIV/AIDS: The Direct and Buffering Effects,” Journal of Behavioral Medicine, Vol. 24, No. 3, 2001, pp. 259-279. doi:10.1023/A:1010718823753
[20]	P. Williams, L. Narciso, et al., “The Prevalence, Correlates, and Costs of Depression in People Living with HIV/AIDS in Ontario: Implications for Service Directions,” AIDS Education and Prevention, Vol. 17, No. 2, 2005, pp. 119-130. doi:10.1521/aeap.17.3.119.62903
[21]	U. Sambamoorthi, J. Walkup, M. Olfson and S. Crystal, “Antidepressant Treatment and Health Services Utilization among HIV-Infected Medicaid Patients Diagnosed with Depression,” Journal of General Internal Medicine, Vol. 15, No. 5, 2000, pp. 311-320. doi:10.1046/j.1525-1497.2000.06219.x
[22]	S. E. Norman, A. D. Chediak, et al., “Sleep Disturbances in Men with Asymptomatic Human Immunodeficiency (HIV) Infection,” Sleep, Vol. 15, No. 2, 1992, pp. 150- 155.
[23]	L. Ferini-Strambi, A. Oldani, et al., “Slow Wave Sleep and Cyclic Alternating Pattern (CAP) in HIV-Infected Asymptomatic Men,” Sleep, Vol. 18, No. 6, 1995, pp. 446-450.
[24]	S. E. Norman, A. D. Chediak, M. Kiel and M. A. Cohn, “Sleep Disturbances in HIV-Infected Homosexual Men,” AIDS, Vol. 4, No. 8, 1990, pp. 775-781. doi:10.1097/00002030-199008000-00009
[25]	T. G. Heckman, J. Miller, et al., “Thoughts of Suicide among HIV-Infected Rural Persons Enrolled in a Telephone-Delivered Mental Health Intervention,” Annals of Behavioral Medicine, Vol. 24, No. 2, 2002, pp. 141-148. doi:10.1207/S15324796ABM2402_11
[26]	A. Komiti, F. Judd, et al., “Suicidal Behaviour in People with HIV/AIDS: A Review,” Australian and New Zealand Journal of Psychiatry, Vol. 35, No. 6, 2001, pp. 747- 757. doi:10.1046/j.1440-1614.2001.00943.x
[27]	N. A. Cooperman and J. M. Simoni, “Suicidal Ideation and Attempted Suicide among Women Living with HIV/AIDS,” Journal of Behavioral Medicine, Vol. 28, No. 2, 2005, pp. 149-156. doi:10.1007/s10865-005-3664-3
[28]	B. Kelly, B. Raphael, F. Judd, et al., “Suicidal Ideation, Suicide Attempts, and HIV Infection,” Psychosomatics, Vol. 39, No. 5, 1998, pp. 405-415.